EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.
Legality of EU environmental regulation challenged under international law.
Increased reliance on indicators can mask an institution’s non-quantifiable policies, Galit A. Sarfaty argues.
A rare strain of E. coli raises tensions and questions over the EU response.
Regulatory agencies change monetary values used when analyzing life-saving regulations.
Private international organizations increasingly set the rules for business activity around the world, but domestic institutions still matter even in setting global rules.
Report finds consumer harm in rise of pay-for-delay agreements.
Defining open government and conceptualizing its success are key first steps in developing a transparency research agenda.
Could regulatory PAYGO work like legislative PAYGO?
The SEC eliminates references to CRA ratings from its rules, while the EU increases its oversight of CRAs.
Studies show that the environmental and health benefits of the EPA’s proposed rule would significantly outweigh its compliance costs.
New National Center for Advancing Translational Sciences works with pharmaceutical companies to develop drugs.